REBECCA MCLAUGHLIN: Open Payments
NPI 1881092021 · GENEVA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 46 payments from 12 companies in 2025. Trend: 2023 $99 · 2024 $398 · 2025 $1,163
Food & beverage: $1,072Education: $91
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $346 |
| PFIZER INC. | 16 | $201 |
| Lilly USA, LLC | 6 | $117 |
| AstraZeneca Pharmaceuticals LP | 3 | $90 |
| SK Life Science, Inc. | 3 | $86 |
| Genentech USA, Inc. | 3 | $79 |
| ABBVIE INC. | 2 | $60 |
| Janssen Biotech, Inc. | 2 | $58 |
| GENZYME CORPORATION | 1 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
Products named: AJOVY, NURTEC ODT, AMYVID, WAINUA, Ocrevus Zunovo, BOTOX, KESIMPTA, VYEPTI.
Industry payments across IL — which companies pay providers there.
